Maxcyte (MXCT) Current Leases (2020 - 2026)

Maxcyte (MXCT) has reported Current Leases for 7 consecutive years, with $1.5 million the latest figure, recorded in Q2 2026.

• On a quarterly basis, Current Leases rose 16.82% year-over-year to $1.5 million in Q2 2026; TTM through Jun 2026 was $1.5 million, a 16.82% increase from a year earlier, with the FY2025 full-year figure at $1.5 million, up 68.52% from the prior year.
• Current Leases was $1.5 million for Q2 2026 at Maxcyte, up from $1.4 million in the prior quarter.
• Over five years, Current Leases peaked at $1.5 million in Q2 2026 and troughed at $152200.0 in Q3 2022.
• A 5-year average of $855811.1 and a median of $844500.0 in 2024 frame the typical range for Current Leases.
• Across the five-year window, Current Leases sank 73.41% in 2022 and surged 392.99% in 2023, its largest moves.
• Over 5 years, Current Leases stood at $157000.0 in 2022, then soared by 392.99% to $774000.0 in 2023, then grew by 11.63% to $864000.0 in 2024, then surged by 68.52% to $1.5 million in 2025, then climbed by 4.95% to $1.5 million in 2026.
• The last three Current Leases figures came in at $1.5 million (Q2 2026), $1.4 million (Q1 2026), and $1.5 million (Q4 2025), per Business Quant data.